Renaissance Technologies
PRVL

Renaissance Technologies’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Renaissance Technologies’s Portfolio PRVL Stock Details PRVL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
2020
Q3 		$897K Buy
2020
Q2 		$858K Sell
2020
Q1 		$961K Buy